BioXcel LLC 13D and 13G filings for BioXcel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-06 8:29 pm Sale | 2024-06-06 | 13D | BioXcel Therapeutics, Inc. BTAI | BioXcel LLC | 551,914 23.500% | -42,126 (-7.09%) | Filing |
| 2023-09-28 5:00 pm Sale | 2023-09-19 | 13D | BioXcel Therapeutics, Inc. BTAI | BioXcel LLC | 594,040 32.500% | -15,823 (-2.59%) | Filing |